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Separate bodies of literature report that elevated pro-inflammatory cytokines and cortisol
negatively affect hippocampal structure and cognitive functioning, particularly in older
adults. Although interactions between cytokines and cortisol occur through a variety of
known mechanisms, few studies consider how their interactions affect brain structure. In
this preliminary study, we assess the impact of interactions between circulating levels of
IL-1Beta, IL-6, IL-8, IL-10, IL-12, TNF-alpha, and waking cortisol on hippocampal volume.
Twenty-eight community-dwelling older adults underwent blood draws for quantification
of circulating cytokines and saliva collections to quantify the cortisol awakening response.
Hippocampal volume measurements were made using structural magnetic resonance
imaging. Elevated levels of waking cortisol in conjunction with higher concentrations
of IL-6 and TNF-alpha were associated with smaller hippocampal volumes. In addition,
independent of cortisol, higher levels of IL-1beta and TNF-alpha were also associated
with smaller hippocampal volumes. These data provide preliminary evidence that higher
cortisol, in conjunction with higher IL-6 and TNF-alpha, are associated with smaller
hippocampal volume in older adults. We suggest that the dynamic balance between the
hypothalamic-pituitary adrenal axis and inflammation processes may explain hippocampal
volume reductions in older adults better than either set of measures do in isolation.
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INTRODUCTION
Cytokines are small proteins, which are produced by a variety of
immune cells (lymphocytes, macrophages, natural killer cells etc.)
and are critically important for cell signaling during when the
immune system is mounting inflammatory responses to infection
and cell damage. Cortisol is an adrenal glucocorticoid hormone
produced in the zona fasciculate of the adrenal cortex and has a
critical role in several physiological systems including acting as a
anti-inflammatory agent.
Glucocorticoids and several cytokines have been associated
with decreased hippocampal volumes and associated cognitive
impairments. Endogenous cortisol levels have consistently been
shown to predict smaller hippocampal volumes, faster hippocam-
pal atrophy, and memory deficits (Lupien et al., 1998; O’Hara,
2007; O’Hara et al., 2007). Exogenous glucocorticoids can also
adversely affect both hippocampal morphology and function dur-
ing cognitive tasks (Hsu et al., 2002; de Quervain et al., 2003;
Brown et al., 2004; Abercrombie et al., 2011) in humans, poten-
tially by inhibiting neurogenesis and/or increasing the risk of cell
death (Woolley et al., 1990; Sapolsky, 2000; Hsu et al., 2002).
Specific cytokines e.g., IL-6, have been found to be inversely cor-
related with hippocampal gray matter volumes (Tanabe et al.,
1997; Marsland et al., 2008) and can adversely affect hippocampal
morphology during development in animalmodels (Kraemer and
Blasey, 2004; Samuelsson et al., 2006). Both IL-1Beta and TNF-
Alpha have also been shown to inhibit long-term potentiation and
synaptic plasticity in the hippocampus and potentially contribute
to excitotoxicity (Marques-Deak et al., 2005; Hermann et al.,
2006; Pickering and O’Connor, 2007). In humans TNF-alpha
single nucleotide polymorphisms predict smaller hippocampal
volumes (Chapman et al., 1987; Spath-Schwalbe et al., 1998;
Baune et al., 2012).
Glucocorticoids and cytokines exert their effects on the brain
by acting directly on receptors and indirectly through a variety
ofmechanisms such as neurotransmission, intracellular signaling,
and subsequent gene expression. Cortisol receptors are expressed
in the hippocampus and many other cortical and subcortical
regions of the humans brain (Sarrieau et al., 1986; Jonat et al.,
1990; Pariante et al., 1999; Pace et al., 2007). Cortisol can pene-
trate the blood brain barrier in order to bind to these receptors
(Woolley et al., 1990; Sapolsky, 2000; Pariante et al., 2004).
Similarly, for cytokines there is evidence from both human and
animal studies that IL-1, IL-6, and TNF-alpha protein and/or
receptors are expressed in hippocampus (Schöbitz et al., 1994;
Banks et al., 1995; Chandler et al., 1997; Vitkovic et al., 2000a,b;
Quan et al., 2003; Reiche et al., 2004; Yamamoto et al., 2006;
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Yirmiya and Goshen, 2011). Furthermore, microglia located
throughout the brain express IL-1Beta, IL-6, IL-8, IL-10, IL-12,
IL-15, and TNF-alpha as well as the IL-1R1 (receptor) (Lee et al.,
2002) which interacts with IL-1Beta and is dynamically expressed
in rat hippocampal neurons.
The biological actions of pro-inflammatory cytokines and glu-
cocorticoids are not independent of each other and interact on
multiple levels. Chronic exposure to glucocorticoids are known
to inhibit the immune system cells responsible for producing
peripheral cytokines (Dhabhar, 2009). Glucocorticoids can exert
broad anti-inflammatory effects by inhibiting the transcription
and action of many of the pro-inflammatory cytokines including
IL-1Beta, IL-6, TNF-Alpha, and others (see Webster et al., 2002
for a review). Cytokines can also exert influence over glucocor-
ticoid secretion, bioavailability, and signaling. IL-1Beta and IL-6
can activate the HPA axis (Berkenbosch et al., 1987; Mastorakos
et al., 1993; Shintani et al., 1995; Besedovsky and del Rey, 2000)
directly. Pro-inflammatory cytokines that produce fever can indi-
rectly dislodge significant amounts of biologically inactivated
glucocorticoids from corticosteroid binding globulin in the blood
(Cameron et al., 2010) making cortisol more available to tar-
get tissues. In addition IL-1 and TNF-Alpha can impair cortisol
signaling by interfering with glucocorticoid receptor phospho-
rylation and interactions between the ligand-receptor complex
and glucocorticoid response elements (see Pace et al., 2007 for
review).
Despite many known parallels between cytokine and glucocor-
ticoid influence on the hippocampus, and known physiological
interactions between these systems, relatively few studies have sys-
tematically addressed the issue of interactions between cytokines
and glucocorticoids on the level of gross hippocampal morphol-
ogy. To address this gap in the literature the current study was
designed to characterize the independent and interactive effects
of endogenous levels of cortisol and several major cytokines (IL-
1Beta, IL-6, IL-8, IL-10, IL-12, TNF-alpha), on hippocampal
volume in the elderly.
METHODS AND MATERIALS
Participants included 28 community-dwelling older adults (15
females and 13 males) between 61 and 100 years of age
(mean = 69.0, SD = 8.6). Participants were recruited through
advertisements, contacts with local senior centers, or had previ-
ously participated in studies at Stanford University. All partici-
pants provided written informed consent for their participation
in accordance with the StanfordUniversity internal review board’s
regulations. All participants filled out questionnaires relating
to their current medical conditions and medical history. They
also underwent the Mini-Mental State Exam (MMSE) (Folstein
et al., 1975) and the Structured Clinical Interview for DSM-IV-
TR (SCID). Individuals with a MMSE less than 26 or with any
Axis I psychiatric disorders were excluded. Participants were also
excluded if they were currently using any systemic corticosteroids,
psychotropic medications, short-acting anxiolytics, sedative hyp-
notics, or medications with significant impact on cytokine levels,
cholinergic, or anticholinergic side effects, as well as any FDA-
approved medications for the treatment of Alzheimer’s disease.
Some participants had a prior history of high blood pressure,
or other cardiovascular issues, all of which were stabilized or
resolved at the time of the study. Those individuals with unre-
solved health issues were not included in the study.
Upon entry into the study, all participants had whole blood
drawn at the Stanford University Clinical Translational Research
Unit for assessment of circulating cytokine levels. Whole-blood
was collected into 10ml SST tubes (Becton Dickinson, Franklin
Lakes, NJ). Serum was allowed to clot for 30min at room tem-
perature, then spun (1300 rpm for 15min), frozen, and stored
at −75◦C for subsequent cytokine quantification. A high sensi-
tivity multiplexed sandwich immunoassay was used to quantify
IL-1Beta, IL-6, IL-8, IL-10, IL-12, and TNF-alpha, concentra-
tions (Mesoscale Discovery, Gaithersburg, MD). The intra-assay
coefficients of variation were: IL-1Beta (2.7%), IL-6 (4.4%),
IL-8 (9.8%), IL-10 (3.1%), IL-12 (7.0%), and. TNF-alpha (4.2%),
The inter-assay coefficients of variation were: IL-1Beta (3.0%),
IL-6 (5.5%), IL-8 (6.2%), IL-10 (4.9%), IL-12 (8.7%), and. TNF-
alpha (3.0%), The sensitivity of each cytokine assay conducted
was IL-1Beta (1.5 pg/ml), IL-6 (0.4 pg/ml), IL-8 (0.4 pg/ml), IL-
10 (0.6 pg/ml), IL-12 (2.4 pg/ml), and TNF-alpha (0.4 pg/ml).
Participants also completed a salivary cortisol measurement
protocol over 2 consecutive days in their own home. Each par-
ticipant was scheduled to obtain saliva samples at the time of
waking, 30min later, and then at 1200, 1700, and 2100 h. Each
participant was instructed to collect saliva using the Salivette sys-
tem (Sarstedt, Inc., Newton, NC). Participants were instructed to
refrigerate each sample immediately after collection. Participants
then shipped samples to the Stanford Clinical and Translational
Research Unit within a week of collection. Participants were
instructed not to eat, drink, smoke, brush their teeth, or use
mouthwash within the 30min before collection and not to drink
alcohol during the 8–10 h prior to collecting samples or during
the 2 days of collection. No physical saliva stimulants were used.
Our prior work compared actual times recorded by participants at
each saliva collection with a Medication Event Monitoring Units
(MEMS) log and indicated that older adults were highly compli-
ant with the protocol. Samples were stored at −80◦C prior to
analysis. Samples were then centrifuged and analyzed for sali-
vary cortisol using luminescence immunoassay (LIA) reagents
provided by Immuno-Biological Laboratories, Inc. (Hamburg,
Germany). Assay sensitivity was 0.015μg/dl. Intra-assay varia-
tion on three saliva pools of the low, medium, and high controls
were averaged 2.78, 10.45, and 4.79%, respectively. The mean val-
ues of the low, medium, and high controls were 0.054, 0.228,
and 0.863μg/dl. The inter-assay coefficients of variation for the
low, medium, and high controls were 10.9, 10.5, and 5.5%,
respectively.
All MRI scans were performed at the Palo Alto VAHCS on a
General Electric Signa 1.5 Tesla clinical MRI scanner with a stan-
dard radio frequency head coil. Two high resolution anatomical
scans were collected: a Proton density and T2-weighted spin-
echo MRI, TR/TE1/TE2 = 5000/30/80ms, 51 contiguous axial
slices (3mm thickness) covering the entire brain and angulated
parallel to the long axis of the hippocampal formation, 0.976 ×
0.976mm2 in-plane resolution (acquisition time = 17min); and
a Three-dimensional spoiled GRASS (SPGR)MRI of entire brain,
TR/TE = 9/2ms, 15◦ flip angle, perpendicular to the long axis
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of the hippocampus, 0.976 × 0.976mm2 in-plane resolution,
1.5mm slice thickness, no skip (acquisition time = 7min 27 s).
Hippocampal volume measurements were carried out using a
semi-automatic, commercially available, high dimensional brain-
mapping tool (Medtronic Surgical Navigation Technologies,
Louisville, CO). Our group (O’Hara, 2007) and others (Hsu
et al., 2002) have independently validated this method, with high
levels of inter-rater reliability, comparing it with manual hip-
pocampal tracing in patient populations and healthy participants.
Manual and semi-automated volume measurements of the hip-
pocampus generally correlated better than r = 0.9 (Hsu et al.,
2002). However, the semi-automated method depends less on
rater judgment and manual tracing, reducing potential rater bias.
All hippocampal boundaries were visually reviewed on each brain
MRI. If faulty registrations of the hippocampal boundaries were
found, manual corrections were made. No MRI scans had to be
discarded as a result. To adjust for differences in head size, all
hippocampal volumes were normalized to total intracranial vol-
ume (TIV). TIV was identified using a mask containing the brain
as identified on the T2-weighted image, as described previously
(Tanabe et al., 1997). Due to inter-subject differences in brain
coverage during acquisition, we standardized TIV by excluding
all slices below the level of the inferior aspect of the temporal lobe
from the intracranial volume measurement.
In order to test the interactions amongst cytokines, waking
cortisol levels, and hippocampal volumes, we employed a mul-
tiple regression approach. For each cytokine we constructed an
independent multiple regressionmodel that included waking cor-
tisol, age, and sex as covariates and hippocampal volume as the
outcome variable. All measures were entered as continuous mea-
sures with the exception of sex. The main effects of each of the
cytokines and their interaction with hippocampal volume were
tested in these models. All independent variables were centered
in accordance with best statistical practices (Kraemer and Blasey,
2004). Cortisol and cytokine values were also log-transformed, as
these measures often have skewed distributions. After log trans-
formation simple correlations were also used to further describe
the pairwise relationships amongst cytokines, cortisol, and hip-
pocampal volume.
We stress that this is an exploratory study aimed at identifying
any potential relationships between cortisol, cytokines, and hip-
pocampal volumes in an elderly population, in order to generate
hypotheses that can be tested in independent follow up studies.
The exploratory nature of our study is due to the lack of extant
data to suggest which specific cytokines would be most likely to
interact with cortisol on hippocampal volume.
RESULTS
We observed main effects of both cortisol and cytokines on
hippocampal volume. High levels of IL-1Beta (β = −0.59,
p = 0.026) and TNF-alpha (β = −0.44, p = 0.025) were associ-
ated with smaller hippocampal volumes. High levels of cortisol
were associated with smaller hippocampal volumes when the
effects of IL-8, IL-10, or TNF-alpha, were controlled for. However,
when controlling for the other cytokines under investigation this
the relationship between cortisol and hippocampal volume not
achieve significance (See Table 1). A non-parametric Spearman’s
rank correlation also indicated only a trend level inverse rela-
tionship between cortisol and hippocampal volume (r = −0.33,
p = 0.083).
Significant interactions between cortisol and cytokine mea-
sures were also observed. These interactions were between cortisol
and both IL-6 (β = −0.42, p = 0.037; See Figures 1, 2) and TNF-
alpha (β = −0.43, p = 0.047; See Figures 1, 3). Having concur-
rently high cytokine levels and high waking cortisol levels was
associated with smaller hippocampal volumes.
DISCUSSION
Our results suggest elevated levels of either IL-6 or TNF-alpha
in combination with elevated waking cortisol is associated with
reduced hippocampal volume in healthy older participants. This
data also suggests that independent of the effects of cortisol,
higher levels of either IL-1Beta or TNF-alpha are also associated
with lower hippocampal volumes. One outlier was identified in
the TNF-alpha data (far right in Figure 3). However, significant
statistical interactions were observed with or without inclusion or
exclusion of this outlier.
Cortisol and cytokines are both known to affect the
hippocampus and to interact with each other via central and
peripheral mechanisms. Cortisol is generally an inhibitory reg-
ulator of pro-inflammatory cytokine production (IL-1Beta, TNF-
alpha) and action (Marques-Deak et al., 2005; Hermann et al.,
2006). Cortisol is also released in reaction to the presence of pro-
inflammatory cytokines (Chapman et al., 1987; Spath-Schwalbe
et al., 1998). Several cytokines (IL-1Beta, IL-2, IL-4, TNF-alpha,
IFN-α) also exert indirect inhibitory influence over glucocor-
ticoid receptor translocation and signaling (Jonat et al., 1990;
Pariante et al., 1999; Pace et al., 2007). These multiple levels of
physiological interactions between cytokines and cortisol suggest
that there are multiple potential explanations for the statistical
cortisol and cytokine interactions that we observe. Two poten-
tial mechanisms may explain our findings; (1) a dual-toxicity
hypothesis and (2) a peripheral cytokine activation of cortisol
hypothesis.
Under the dual-toxicity hypotheses cortisol and various
cytokines could be both adversely impacting hippocampal tis-
sues resulting in volume decreases. Under the peripheral cytokine
activation of cortisol hypotheses the same results could also
be explained by a peripheral interaction between cytokines and
cortisol. In this scenario, immune triggers could be repeatedly
activating cytokines, which then induce increases in unbound
cortisol. This unbound cortisol can then cross the blood-brain-
barrier and affects the hippocampus as well as other HPA axis
regulatory mechanisms. Repeated immune challenges and subse-
quent cortisol release could also be an underlying mechanism for
hippocampal atrophy.
Some evidence suggests that a central dual toxicity interac-
tion is possible. Hypercortisolemia has been shown to negatively
impact neuronal function in the hippocampus in a range of ani-
mal studies. Specifically there is evidence that glucocorticoids can
alter dendritic morphology, inhibit neurogenesis, and increase the
risk of cell death (Woolley et al., 1990; Sapolsky, 2000).
Despite a limited ability to cross the blood brain barrier
previous studies suggest that peripheral cytokines can still exert
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Table 1 | The effects and interactions of various cytokines and cortisol levels on hippocampal volume (corrected for total intracranial volume).
Outcome Measure Test variable(s) Statistic P-value
Hippocampal volume Omnibus r2 = 0.49, F(5, 22) = 4.21, N = 28 p = 0.008*
TNFam β = −0.44 p = 0.025*
Cortisolm β = −0.37 p = 0.033*
TNFa × Cortisoli β = −0.43 p = 0.047*
Hippocampal volume Omnibus r2 = 0.62, F(5, 17) = 5.46, N = 23 p = 0.004*
IL-Bm β = −0.59 p = 0.026*
Cortisolm β = −0.25 p = 0.307
IL-B × Cortisoli β = −0.41 p = 0.173
Hippocampal volume Omnibus r2 = 0.46, F(5, 22) = 3.73, N = 28 p = 0.014*
IL-6m β = −0.01 p = 0.943
Cortisolm β = −0.22 p = 0.217
IL-6 × Cortisoli β = −0.42 p = 0.037*
Hippocampal volume Omnibus r2 = 0.40, F(5,22) = 2.92, N = 28 p = 0.036*
IL-8m β = −0.02 p = 0.929
Cortisolm β = −0.39 p = 0.039*
IL-8 × Cortisoli β = 0.29 p = 0.152
Hippocampal volume Omnibus r2 = 0.43, F(5, 22) = 3.26, N = 28 p = 0.024*
IL-10m β = −0.33 p = 0.096
Cortisolm β = −0.43 p = 0.025*
IL-10 × Cortisoli β = −0.29 p = 0.169
Hippocampal volume Omnibus r2 = 0.38, F(5, 22) = 2.68, N = 28 p = 0.049*
IL-12m β = −0.24 p = 0.198
Cortisolm β = −0.39 p = 0.051
IL-12 × Cortisoli β = −0.10 p = 0.628
Main effectsm, interactionsi within multiple regression models are indicated for the hippocampal volume. All multiple regression models include covariates for age,
sex, and cortisol. Beta estimates (β) are standardized. All multiple regression models test for the main effect the cytokine, the main effect of cortisol, and the
interaction between cortisol and the cytokine on hippocampal volume. *p < 0.05.
influence on central targets. These effects may be accomplished
via degradation of the blood-brain-barrier, active transport into
the brain, activation of central nervous system cytokines via
neural signals mediated through endothelial cells astrocytes and
glial cells (Banks et al., 1995; Chandler et al., 1997; Quan
et al., 2003; Reiche et al., 2004; Yirmiya and Goshen, 2011).
While less is known regarding the impact of cytokines on
hippocampus, pro-inflammatory cytokines acting centrally can
have many deleterious effects. TNF-alpha in particular has been
shown to contribute to neuronal (Barker et al., 2001; McGuire,
2001) and oligodendroglia cell death (Buntinx et al., 2004a,b;
Li et al., 2008) and to decrease various neurotrophic sup-
port mechanisms that contribute to cell survival (Barker et al.,
2001).
Alternatively there are also mechanisms by which peripheral
cytokine actions could drive systemic hypercortisolemia, which
effects on the hippocampus. Peripheral cytokine actions can
directly activate the HPA axis, interfere with cortisol receptor sig-
naling and indirectly dislodge cortisol from its binding proteins.
These processes can dramatically increase the amount of cor-
tisol disrupting the normally tight regulation of the HPA axis.
Since unbound cortisol passes through the blood-brain-barrier
with high efficiency (Pariante et al., 2004) and is known to exert
effects on the hippocampus (Sapolsky, 2000), this is another
way cortisol and cytokines may interact to affect hippocampal
morphology/physiology.
We have outlined some potential mechanisms that could
underlie the statistical interactions that we observe. However,
it is important to note that our data alone is not sufficient to
support any of these mechanisms. Therefore, follow up studies
are needed to test the validity of these hypothesized mecha-
nisms. Furthermore, additional brain regions outside the hip-
pocampus could have similar relationships with cortisol and
pro-inflammatory cytokines. These relationships will need to be
investigated to determine if these findings are specific to the
hippocampus.
The current study is not without its limitations. First, we
had a small sample size which likely reduced power to detect
all significant relationships. Second, our study is cross-sectional,
thus the directionality of the relationships we observe is cur-
rently unknown and potentially bidirectional. Thus, with these
data alone we cannot determine cause and effect relationships
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FIGURE 1 | Significant main effects and interactions between
cytokines, waking cortisol, and hippocampal volume.
FIGURE 2 | A significant interaction between IL-6 and cortisol on
hippocampal volumes. Higher waking cortisol and concurrently high levels
of IL-6 are associated with smaller hippocampal volumes. “Lower” and
“higher” waking cortisol levels are displayed as a median split to allow the
visualization of the multiple regression results. However, continuous
variables were used in all multiple regressions models.
between hippocampal volume changes, cytokines, and cortisol.
Longitudinal investigations are required to best address these
issue of directionality and order of causation. Third, using MRI
it is not possible to distinguish between processes that result in
cell death and processes that result in changes in morphology.
Necrotic and apoptotic processes may underlie the hippocam-
pal volume changes that we observe to be associated with the
interactions of cortisol and cytokines. However, other cellular
processes such as dendritic atrophy or other cellular morphol-
ogy changes may also be responsible (Gould et al., 1990; Woolley
et al., 1990; Hook et al., 2007). Fourth, while participants in
this study were healthy older adults, we did not assess body
mass index or other physiological measures concurrently with our
measures of HPA and immune function. This could partially limit
FIGURE 3 | A significant interaction between TNF-alpha and cortisol
on hippocampal volumes. Higher waking cortisol and concurrently high
levels of TNF-alpha are associated with smaller hippocampal volumes.
“Lower” and “higher” waking cortisol levels are displayed as a median split
to allow the visualization of the multiple regression results. However,
continuous variables were used in all multiple regressions models.
our ability to detect potential significant findings. Finally, given
the absence of any studies examining the interactive effects of
cytokines and cortisol levels in this population, we did not have
sufficient information to identify a smaller number of cytokine
measures for specifying more definitive a priori hypotheses. As
such, this is an exploratory, hypothesis generating investigation,
which included measures of multiple cytokines. Significance lev-
els obtained here would not withstand Bonferroni correction.
Accordingly our results should be interpreted within that con-
text and be used to inform future hypothesis driven studies that
cover a narrower scope of observation and address the limitations
described here.
In summary, we provide preliminary evidence for interac-
tions between pro-inflammatory cytokine levels, waking cor-
tisol secretion levels, and hippocampal volumes. Specifically
we found evidence that higher levels of IL-6 or TNF-alpha
in conjunction with higher cortisol levels are associated with
smaller hippocampal volumes. Our data suggest that the inter-
action between waking cortisol and pro-inflammatory cytokines
may be as critical an indicator of hippocampal volume-
loss as the action of any of these measures in isolation.
We suggest that these interactions may be due to either a
dual toxicity scenario whereby cortisol and pro-inflammatory
cytokines act synergistically on the hippocampus or that
cytokines, acting outside of the central nervous system, are
driving up levels of unbound cortisol which penetrate the
blood-brain-barrier and, over time, cause hippocampal volume
changes.
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